No Data
Has Chemed Corporation (NYSE:CHE) Stock's Recent Performance Got Anything to Do With Its Financial Health?
Reasons to Retain Chemed Stock in Your Portfolio Now
Exxon Mobil, Chemed, Las Vegas Sands And More On CNBC's 'Final Trades'
Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future
Chemed Insider Sold Shares Worth $1,197,620, According to a Recent SEC Filing
Oppenheimer Maintains Chemed(CHE.US) With Buy Rating, Maintains Target Price $650
Oppenheimer analyst Michael Wiederhorn maintains $Chemed(CHE.US)$ with a buy rating, and maintains the target price at $650.According to TipRanks data, the analyst has a success rate of 69.3% and a